✦ LIBER ✦

Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?

✍ Scribed by T. Le; H. Latifah; L. Jolicoeur; J. Weberpals; W. Faught; L. Hopkins; M. Fung Kee Fung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternative intraperitoneal chemotherapy

✍ Heidi J. Gray; Chirag A. Shah; Ron E. Swensen; Hisham K. Tamimi; Barbara A. Goff 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Intraperitoneal chemotherapy is appropri

✍ Maurie Markman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Neoadjuvant chemotherapy and interval de

✍ J. Jacob; D. Gershenson; M. Morris; L. Copeland; T. Burke; J. Wharton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Neoadjuvant chemotherapy and interval de

✍ Joseph H. Jacob; David M. Gershenson; Mitchell Morris; Larry J. Copeland; Thomas 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Intraperitoneal chemotherapy for optimal

✍ A. González Martín 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 44 KB

Laparoscopic debulking of advanced stage

✍ I. Atlas 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB